CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 34 filers reported holding CYTOSORBENTS CORP in Q2 2017. The put-call ratio across all filers is 2.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $20 | -99.9% | 1,687 | +16.0% | 0.00% | – |
| Q3 2022 | $17,000 | 0.0% | 1,454 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $17,000 | 0.0% | 1,454 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | – | 1,454 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2020 | $16,000 | 0.0% | 1,967 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $16,000 | – | 1,967 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2018 | $6,000 | -82.9% | 430 | -92.3% | 0.00% | -100.0% |
| Q3 2017 | $35,000 | +45.8% | 5,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $24,000 | -4.0% | 5,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $25,000 | -19.4% | 5,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $31,000 | -13.9% | 5,600 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $36,000 | +44.0% | 5,600 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $25,000 | -19.4% | 5,600 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $31,000 | – | 5,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |